ABBV
AbbVie Inc
264.00$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.2% | 19.7% | 22.8% | 25.0% | 23.6% | 22.4% | 33.6% | 31.0% | 30.0% | 37.6% | 30.0% | 29.8% | |
| 77.8% | 80.3% | 77.2% | 75.0% | 76.4% | 77.6% | 66.4% | 69.0% | 70.0% | 62.4% | 70.0% | 70.2% | |
| 18.3% | 19.4% | 17.9% | 18.9% | 32.8% | 20.4% | 16.9% | 14.3% | 11.2% | 14.1% | 22.7% | 14.9% | |
| 26.8% | 21.7% | 19.8% | 19.1% | 19.1% | 17.6% | 17.6% | 18.2% | 22.8% | 19.7% | 19.7% | 22.9% | |
| 60.7% | 47.3% | 40.8% | 41.2% | 56.9% | 38.6% | 41.6% | 37.1% | 38.8% | 38.9% | 53.8% | 37.4% | |
| 17.1% | 33.0% | 36.4% | 33.8% | 19.5% | 39.0% | 24.8% | 31.9% | 31.2% | 23.5% | 16.2% | 32.8% | |
| 2.1% | 3.1% | 4.1% | 4.1% | 4.1% | 5.4% | 5.4% | 4.3% | 3.8% | 4.1% | 5.0% | 4.7% | |
| 11.9% | 29.1% | 30.8% | 27.4% | 15.9% | 25.3% | 7.4% | 23.1% | 23.2% | 11.5% | 6.6% | 10.8% | |
| 3.0% | 6.6% | 7.5% | 8.6% | -1.5% | 1.6% | -2.7% | 2.6% | 2.8% | 2.5% | -1.0% | 3.9% | |
| 8.9% | 22.5% | 23.2% | 18.8% | 17.4% | 23.7% | 10.1% | 20.5% | 20.4% | 9.0% | 7.6% | 6.9% | |
| 18.0% | 35.9% | 39.5% | 36.8% | 25.4% | 36.8% | 26.9% | 42.6% | 41.6% | 31.6% | 26.5% | 28.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.